Department of General Surgery, Ankara Oncology Education and Research Hospital, Ankara Turkey.
Am J Otolaryngol. 2011 Sep-Oct;32(5):398-401. doi: 10.1016/j.amjoto.2009.12.005. Epub 2010 Oct 30.
Total or near-total thyroidectomy is advocated in reducing the recurrence rate and improving survival in differentiated thyroid carcinoma. However, this potential benefit could be seen in all patient groups or only in the patients who have multifocal disease. We analyzed the clinical significance of occult multifocal disease in patients with completion thyroidectomy.
Ninety-seven patients in whom the completion thyroidectomy was performed within 6 months were included. The patients were grouped according to whether they have malignancy in the remnant thyroid tissue. The groups were examined and compared according to patients and tumor characteristics. The effect of the presence of residual tumor in remnant thyroid tissue on clinical course, disease-free survival, and overall survival were evaluated as well.
After completion thyroidectomy, 20 (20.6%) of the 97 patients revealed additional cancer focus in the residual tissue. Median follow-up period was 104 months (range, 84-205 months). Only tumor multifocality in the resected lobe after first surgery was predictive of the presence of malignancy in the thyroid remnant (P = .002; relative risk, 4.9; 95% confidence interval, 1.7-14.5). Detection of malignancy in the remnant thyroid tissue did not affect the disease-free survival (P = .39). There were no deaths in patients who underwent reoperative thyroid surgery.
Only tumor multifocality in the original thyroid lobe was predictive of finding additional cancer in the contralateral lobe. However, clinical significance of occult multifocal disease was not shown.
全甲状腺切除术或近全甲状腺切除术可降低分化型甲状腺癌的复发率并提高生存率。然而,这种潜在的获益可能仅见于多灶性疾病患者,或者见于所有患者群体中。我们分析了在接受甲状腺全切术后隐性多灶性疾病在患者中的临床意义。
本研究纳入了 97 例在 6 个月内接受甲状腺全切术的患者。根据残余甲状腺组织中是否存在恶性肿瘤将患者分组。根据患者和肿瘤特征对各组进行检查和比较。同时评估残余甲状腺组织中残留肿瘤的存在对临床病程、无病生存率和总生存率的影响。
在完成甲状腺切除术之后,97 例患者中有 20 例(20.6%)在残余组织中发现了其他癌症病灶。中位随访时间为 104 个月(范围 84-205 个月)。仅首次手术后切除的甲状腺叶中存在肿瘤多灶性与甲状腺残余组织中存在恶性肿瘤相关(P =.002;相对风险 4.9;95%置信区间 1.7-14.5)。残余甲状腺组织中恶性肿瘤的检出并不影响无病生存率(P =.39)。接受再次甲状腺手术的患者均未死亡。
仅原始甲状腺叶中的肿瘤多灶性与对侧叶中发现额外癌症相关。然而,隐性多灶性疾病的临床意义尚未得到证实。